The Oncology Marketing Strategies U.S. 2008 report provides:

• Cancer-specific analysis and the implications for manufacturers of new government policies as well as public and private sector reimbursement trends
• Insights into the pros and cons of product marketing channel strategies, including specialty pharmacies, distributors and wholesalers
• Evaluations of key physician and patient influencers; including patient assistance plan and reimbursement support providers, GPOs, and advocacy groups
• Comprehensive overview of key sales and marketing targets – both community and institutional customers – which ultimately utilize oncology drug products
• Identification of strategic opportunities for oncology manufacturers to build a cancer franchise and drive product utilization
• Comprehensive market intelligence to increase sales and marketing ROI

Unique Features

• Robust data, including primary survey work – feedback from over 130 oncologists, 25 practice managers and 50 managed care (medical and pharmacy directors) representatives
• Practice economic and operational insights gained through the OMS team’s consulting relationship with a 10-physician oncology group
• Direct access to the industry’s leading cancer marketing analytics team
• Regular in-person updates on reimbursement trends and policy developments, as well as other research highlights with custom recommendations tailored to address client needs
• Timely analysis of current issues affecting oncology, including Medicare reform (e.g., Part D, ESA rulings), reimbursement, distribution channel evolution, patient assistance programs
• Comprehensive profiles of leading oncology market players, including pharmaceutical manufacturers, specialty, mail order and retail pharmacies, PBMs, government and commercial payers, wholesalers, patient assistance program/reimbursement services vendors and other oncology stakeholders

Oncology Marketing Strategies™ Europe is a guide to optimizing coverage of and access to cancer products in Europe. Together, coverage and access are the foundation for successful marketing and sales efforts. Research for Oncology Marketing Strategies Europe is conducted by MattsonJack’s European consulting team based in Paris and includes extensive primary research with providers, distributors, funding authorities and regulatory experts in France, Germany, Italy, Spain and the United Kingdom. Subscribers will:

• Recognize the impact of national government policy, and regional and local policy on European cancer drug business
• Understand each country’s health care delivery model, including each model’s impact on the coverage of cancer treatments
• Gain insights into drivers of oncologists’ product selection
• Identify key influencers of rapid uptake for new cancer drugs and new indications
• Follow each country’s varied sites of cancer care, oncology drug channels and their associated economics

For more information on MattsonJack DaVinci's Oncology Marketing Strategies™ or other multiclient offerings, phone 650-403-7001 or e-mail info@mattsonjack.com.